It was reported that CARD11 contributes to ibrutinib resistance in cancer (Grommes et al. 2017; Wu et al. 2016) supporting our observation that CARD11 could play role in drug resistance phenotype of HCT116 p53 −/− cells. This evidence concerns the gene TP53 and cancer.